5-(5-amino-3,3-dimethyl-6-nitro-2-oxo-2,3-dihydro-indol-1-yl)-pentanoic acid ethyl ester | 869846-30-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: 5-(5-amino-3,3-dimethyl-6-nitro-2-oxo-2,3-dihydro-indol-1-yl)-pentanoic acid ethyl ester
• 英文别名: Ethyl 5-(5-amino-3,3-dimethyl-6-nitro-2-oxoindol-1-yl)pentanoate
• CAS: 869846-30-0
• 化学式: C₁₇H₂₃N₃O₅
• 分子量: 349.387
• InChiKey: QVTMWEWXRGXOOL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  25
• 可旋转键数：
  7
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.53
• 拓扑面积：
  118
• 氢给体数：
  1
• 氢受体数：
  6

文献信息

• Pyrrolobenzimidazolones and their use as antiproliferative agents
  申请人：Boehringer Ingelheim International GmbH

  公开号：EP1598353A1

  公开（公告）日：2005-11-23

  The invention relates to pyrrolobenzimidazolone compounds of formula (I), wherein A,T and R1 to R3 are defined as in claim 1, which possess tubulin inhibitory activity and are suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation and the use thereof for preparing a pharmaceutical composition.

  该发明涉及式(I)的吡咯苯并咪唑酮化合物，其中A、T和R1至R3的定义如权利要求书中所述，具有微管抑制活性，适用于治疗由细胞过度或异常增殖所特征的疾病，并用于制备药物组合物。
• N-alkoxy-4,4-dioxy-polyalkyl-piperidine compounds, their corresponding N-oxides and controlled radical polymerization therewith
  申请人：Nesvadba Peter

  公开号：US20060149011A1

  公开（公告）日：2006-07-06

  The present invention relates to selected 1-alkoxy-2,2,6,6 tetramethyl piperidine, 1-alkoxy-2,2 diethyl-6,6 dimethyl piperidine and 1-alkoxy-2,6 diethyl-2,3,6 dimethyl piperidine derivatives which are substituted in the 4 position by two oxygen atoms forming an open chain or cyclic ketal structure, a polymerizable composition comprising a) at least one ethylenically unsaturated monomer and b) said piperidine derivatives. Further aspects of the present invention are a process for polymerizing ethylenically unsaturated monomers, and the use of 1-alkoxy-2,2,6,6 tetramethyl piperidine, 1-alkoxy-2,2 diethyl-6,6 dimethyl piperidine and 1-alkoxy-2,6 diethyl-2,3,6 dimethyl piperidine derivatives which are substituted in the 4 position by two oxygen atoms forming an open chain or cyclic ketal structure for controlled polymerization. The intermediate N-oxyl derivatives, a composition of the N-oxyl derivatives with ethylenically unsaturated monomers and a free radical initiator, as well as a process for polymerization are also subjects of the present invention.

  本发明涉及选择的1-烷氧基-2,2,6,6四甲基哌啶，1-烷氧基-2,2二乙基-6,6二甲基哌啶和1-烷氧基-2,6二乙基-2,3,6二甲基哌啶衍生物，其在4位被两个氧原子取代，形成开链或环状璃缩酮结构，包括a）至少一种乙烯基不饱和单体和b）所述哌啶衍生物的可聚合组合物。本发明的其他方面包括聚合乙烯基不饱和单体的方法，以及使用1-烷氧基-2,2,6,6四甲基哌啶、1-烷氧基-2,2二乙基-6,6二甲基哌啶和1-烷氧基-2,6二乙基-2,3,6二甲基哌啶衍生物，其在4位被两个氧原子取代，形成开链或环状璃缩酮结构，用于受控聚合。中间体N-氧基衍生物，N-氧基衍生物与乙烯基不饱和单体和自由基引发剂的组合物，以及聚合方法也是本发明的对象。
• Pyrrolobenzimidazolones and their use as anti-proliferative agents
  申请人：McConnel Darryl

  公开号：US20050261350A1

  公开（公告）日：2005-11-24

  The invention relates to pyrrolobenzimidazolone compounds of formula (I), wherein A, T and R 1 to R 3 are defined as in claim 1, which are suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation and the use thereof for preparing a pharmaceutical composition.

  本发明涉及式（I）的吡咯苯并咪唑酮化合物，其中A、T和R1至R3如权利要求1所定义，适用于治疗由过度或异常细胞增殖所特征的疾病，并用于制备制药组合物。
• PYRROLOBENZIMIDAZOLONES AND THEIR USE AS ANTIPROLIFERATIVE AGENTS
  申请人：Boehringer Ingelheim International GmbH

  公开号：EP1756112A1

  公开（公告）日：2007-02-28
• US7288613B2
  申请人：——

  公开号：US7288613B2

  公开（公告）日：2007-10-30